Business- Page 77

ROCKVILLE, MD, Nov. 03, 2026 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced the appointments of

SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) — Cibus, Inc. (Nasdaq: CBUS), a technology company that uses biology to produce sustainable ingredients and helps farmers grow more food with fewer inputs, today

Approximated TTM Subscription Revenue Contribution for ≥$30K ARR Customers Grew 18% year-over-year CHICAGO, Nov. 03, 2026 (GLOBE NEWSWIRE) — Sprout Social, Inc. (“Sprout Social”, the “Company”) (NASDAQ: SPT), a leading AI-powered Social

AUSTIN, Texas, Nov. 03, 2026 (GLOBE NEWSWIRE) — Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that members of

VISTA, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) — Flux Power Holdings, Inc. (NASDAQ: FLUX) (“Flux Power” or the “Company”), a leading developer of advanced lithium-ion energy storage solutions and fleet intelligence technology,

HOUSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) — Powell Industries, Inc. (NASDAQ: POWL), a leading supplier of custom engineered solutions for the management, control and distribution of electrical energy, today announced that it

SUNNYVALE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) — CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported

FREMONT, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) — Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today reported financial results for the

THOUSAND OAKS, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) — Latigo Biotherapeutics, Inc. (Nasdaq: LTGO), a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines, today announced that management will participate in